Nanologica AB (publ) (STO:NICA)
Sweden · Delayed Price · Currency is SEK 0.1600
-0.0090 (-5.33%)
Nov 3, 2026, 5:25 PM CET
Nanologica AB Market Cap
Nanologica AB has a market cap or net worth of 52.6 million as of November 3, 2026. It is the 44,510th most valuable company in the world and the 674th biggest in Sweden. Its market cap has decreased by 52.76% in one year.
Market Cap
52.60M
Enterprise Value
87.17M
Revenue
129.48M
Global Rank
Country Rank
#674 Sweden
PE Ratio
1.66
ChartMarket Cap Chart
Since October 30, 2015, Nanologica AB's market cap has decreased from 73.54M to 52.60M, a decrease of -28.47%. That is a compound annual growth rate of -3.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 52.60M | -23.68% |
| Dec 30, 2025 | 68.93M | -57.14% |
| Dec 30, 2024 | 160.81M | -57.22% |
| Dec 29, 2023 | 375.92M | 33.47% |
| Dec 30, 2022 | 281.66M | -27.01% |
| Dec 30, 2021 | 385.87M | 3.67% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alzinova AB | 112.04M |
| Active Biotech AB | 105.31M |
| OncoZenge AB | 85.84M |
| Ascelia Pharma AB | 77.45M |
| Pila Pharma AB | 71.26M |
| AcouSort AB | 68.15M |
| Annexin Pharmaceuticals AB | 57.89M |
| Fluicell AB | 38.33M |